Close Menu

iPS on the Way

Two teams report creating mice from iPS cells. In Nature, researchers led by the Chinese Academy of Sciences' Qi Zhou followed Kyoto University's Shinya Yamanaka's protocol and used viral vectors to introduce four factors into mouse fibroblast cells to reprogram them. Zhou's group was able to get 27 live mouse births with their best method getting 22 live births at a success rate of 3.5 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.